Serum levels of leptin and homocysteine in women with polycystic ovary syndrome and its relationship to endocrine, clinical and metabolic parameters

dc.contributor.authorAtamer, A.
dc.contributor.authorDemir, B.
dc.contributor.authorBayhan, G.
dc.contributor.authorAtamer, Y.
dc.contributor.authorIlhan, N.
dc.contributor.authorAkkus, Z.
dc.date.accessioned2026-08-12T17:13:45Z
dc.date.issued2008
dc.departmentFırat Üniversitesi
dc.description7th International Congress on Coronary Artery Disease -- OCT 07-10, 2007 -- Venice, ITALY
dc.description.abstractWe examined the relationship between endocrine, clinical and metabolic parameters in 35 women (mean age 27.3 years) with polycystic ovary syndrome (PCOS) and 30 age- and body mass index-matched normal ovulatory women. In PCOS women, serum leptin, homocysteine, insulin, insulin-like growth factor-1, insulin-like growth factor binding protein-3 levels and the insulin resistance index (HOMA-IR) were significantly higher, while sex hormone-binding globulin and high-density lipoprotein cholesterol levels were lower compared with healthy women. Serum luteinizing hormone (LH), estradiol (E-2), androstenedione, testosterone and dehydroepiandrosterone sulphate levels were found to be significantly higher in PCOS women compared with healthy women. The levels of E-2, LH and testosterone were positively correlated with leptin levels in PCOS women. Similarly, androstenedione levels and HOMA-IR were positively correlated with homocysteine levels and insulin levels were positively correlated with LH. We conclude that increased homocysteine levels, hyperandrogenaemia, insulin resistance and impaired lipid metabolism contribute to the risk of premature atherosclerosis in PCOS women.
dc.identifier.doi10.1177/147323000803600113
dc.identifier.endpage105
dc.identifier.issn0300-0605
dc.identifier.issn1473-2300
dc.identifier.issue1
dc.identifier.orcid0000-0002-6161-3666
dc.identifier.orcid0000-0002-0208-8929
dc.identifier.pmid18230273
dc.identifier.scopus2-s2.0-39149085035
dc.identifier.scopusqualityQ2
dc.identifier.startpage96
dc.identifier.urihttps://doi.org/10.1177/147323000803600113
dc.identifier.urihttps://hdl.handle.net/11508/51551
dc.identifier.volume36
dc.identifier.wosWOS:000253171700013
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSage Publications Ltd
dc.relation.ispartofJournal of International Medical Research
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectpolycystic ovary-syndrome
dc.subjectinsulin resistance
dc.subjectinsulin-like growth factors
dc.subjectsex steroids
dc.subjectlipid metabolites
dc.subjectleptin
dc.subjecthomocysteine
dc.titleSerum levels of leptin and homocysteine in women with polycystic ovary syndrome and its relationship to endocrine, clinical and metabolic parameters
dc.typeConference Object

Dosyalar